SCHEMBL20164626

SCHEMBL20164626

CCCNc1nc(Cl)nc2c(NC(C)(C)CO)nc(Cl)nc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.44
SLC29A1 Q99808 6/20 0.42
PDE10A Q9Y233 1/20 0.35
CCNE2 O96020 1/20 0.35
CDK4 P11802 1/20 0.35
CCND1 P24385 1/20 0.35
CCNE1 P24864 1/20 0.35
CDK2 P24941 1/20 0.35
HTT P42858 1/20 0.32
NR1I2 O75469 1/20 0.32
AHR P35869 1/20 0.32
HDAC1 Q13547 2/20 0.32
HDAC2 Q92769 2/20 0.32
HDAC3 O15379 1/20 0.32
HDAC4 P56524 1/20 0.32
HDAC7 Q8WUI4 1/20 0.32
HDAC10 Q969S8 1/20 0.32
HDAC11 Q96DB2 1/20 0.32
HDAC8 Q9BY41 1/20 0.32
HDAC6 Q9UBN7 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16094375 0.82 SLC29A1 (0.47) KMT2ASLC29A1PDE10ANR1I2AHR
SCHEMBL20164491 0.81 SLC29A1 (0.46) KMT2ASLC29A1CCNE2CDK4CCND1
SCHEMBL20164638 0.81 SLC29A1 (0.54) KMT2ASLC29A1PDE10AHTTNR1I2
Hydrochloric Acid SCHEMBL20164513 0.80 SLC29A1 (0.44) KMT2ASLC29A1CCNE2CDK4CCND1
SCHEMBL20164648 0.79 KMT2A (0.43) KMT2ASLC29A1PDE10ANR1I2AHR
SCHEMBL20164645 0.78 SLC29A1 (0.51) KMT2ASLC29A1PDE10AHTTNR1I2
SCHEMBL20164668 0.76 SLC29A1 (0.44) KMT2ASLC29A1PDE10AHTTNR1I2
SCHEMBL20164779 0.76 SLC29A1 (0.42) KMT2ASLC29A1PDE10ANR1I2AHR
SCHEMBL20164769 0.73 SLC29A1 (0.42) KMT2ASLC29A1PDE10AHTTNR1I2
SCHEMBL20164669 0.73 SLC29A1 (0.42) KMT2ASLC29A1PDE10AHTTNR1I2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3316890-B1 NOVEL BREATHING CONTROL MODULATING COMPOUNDS, AND METHODS OF MAKING AND USING SAME NEURAD LTD (IL) 2023-09-06 EP disclosed
US-10294228-B2 Breathing control modulating compounds, and methods of making and using same NEURAD LTD. (IL) 2019-05-21 US disclosed
US-20180141953-A1 Novel Breathing Control Modulating Compounds, and Methods of Making and Using Same NEURAD LTD. (IL) 2018-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180141953-A1 Novel Breathing Control Modulating Compounds, and Methods of Making and Using Same MTNR1B, CHRM3, PER2 KMT2A 2456/4885SLC29A1 4472/4885PDE10A 154/4885
US-10294228-B2 Breathing control modulating compounds, and methods of making and using same MTNR1B, PDE3A, CHRM3 KMT2A 2528/4885SLC29A1 4518/4885PDE10A 192/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.